arrow
L

Lorenzo Tosco

Magna Graecia University of Catanzaro
H指数:19
被引数:1,362
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)

“ARNEO”高危及前列腺癌术前新辅助德加瑞利克斯联合或不联合阿帕卢他胺的随机II期试验最终结果

2025-12-290
PRE
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort

pN1前列腺癌根治性前列腺切除术后预后分层:一项多中心队列的竞争风险分析

2025-08-070
PREAI
A new mini-invasive surgical treatment for Peyronie's disease: mechanically processed lipoaspirates as regenerative therapy

一种治疗佩罗尼氏病的新型微创手术治疗:机械处理的脂肪抽吸物作为再生疗法

2025-08-010
PRE
NATURAL HISTORY OF PN1 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: COMPETING RISK ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES
2024-05-010
PRE
The habits of European urologists in the field of cryopreservation before the urological cancers treatment
2024-01-061
OA
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

ARNEO: 根治性前列腺切除术前加或不加阿帕鲁胺的新辅助地加瑞克治疗高危前列腺癌的随机II期试验

2023-06-0127
PRE
Minimally Invasive Buccal Mucosa Dorsal Graft for Female Distal Urethroplasty

微创颊粘膜背侧移植用于女性远端尿道成形术

2021-02-015
OAAI
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery

Decipher测试预测高危非转移性前列腺癌患者术后10年远处转移复发的有效性

2019-09-0119
OAAI
Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review

对寡转移性前列腺癌管理的新见解: 全面回顾

2019-03-0165
OAAI
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer
2019-01-0154
OAAI
Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy

透明细胞肾细胞癌的分子亚型是完全转移切除术后预后的预后因素

2018-10-0142
PREAI
Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series
2018-09-017
OAAI
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis
2018-05-0119
OAAI
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
2018-04-0217
OAAI
Comparison of Functional Outcome after Extended versus Super-Extended Pelvic Lymph Node Dissection during Radical Prostatectomy in High-Risk Localized Prostate Cancer

高危局限性前列腺癌根治术中扩大与超扩大盆腔淋巴结清扫术后功能结局的比较

2017-11-228
OAAI
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series
2017-06-0170
PREAI
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
2017-05-0925
PREAI
HISTORICAL TRENDS IN HIGH-RISK PROSTATE CANCER PATIENTS CHARACTERISTICS: A 27 YEARS OLD OBSERVATIONAL STUDY FROM A MULTICENTER PROSTATE CANCER CLINICAL AND TRANSLATIONAL RESEARCH GROUP
2016-04-010
OA
PATTERNS AND PREDICTORS OF CLINICAL RECURRENCE FOLLOWING EARLY SALVAGE RADIATION THERAPY IN PATIENTS WITH PSA RISE AFTER RADICAL PROSTATECTOMY: A LONG TERM MULTI-INSTITUTIONAL ANALYSIS
2016-04-010
OAAI
LONG-TERM IMPACT OF ADJUVANT VERSUS EARLY SALVAGE RADIATION THERAPY ON CLINICAL RECURRENCE IN PT3N0 PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF AMULTI-INSTITUTIONAL ANALYSIS
2016-04-010
OAAI